Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

NantHealth Inc (NH) USD0.0001

Sell:$0.91 Buy:$0.92 Change: $0.0466 (5.35%)
NASDAQ:0.20%
Market closed |  Prices as at close on 13 December 2019 | Switch to live prices |
Sell:$0.91
Buy:$0.92
Change: $0.0466 (5.35%)
Market closed |  Prices as at close on 13 December 2019 | Switch to live prices |
Sell:$0.91
Buy:$0.92
Change: $0.0466 (5.35%)
Market closed |  Prices as at close on 13 December 2019 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

NantHealth, Inc. is a healthcare cloud-based information technology (IT) company. The Company is engaged in converging science and technology through a single integrated clinical platform, to provide actionable health information at the point of care. As of December 31, 2017, the Company conducted its operations primarily in the United States, Canada, the United Kingdom and Singapore. Its solutions include molecular profiling solution, software, and hardware systems infrastructure, which integrates patient data management, bioinformatics, and molecular medicine, enabling care and clinical practice. Its cancer care solutions include a set of interoperability, diagnostics, risk stratification and decision support solutions (Eviti). Its systems infrastructure collects, indexes, analyzes and interprets billions of molecular, clinical, operational and financial data points derived from sources to improve decision-making.

Contact details

Address:
9920 JEFFERSON BLVD
CULVER CITY
90232-3506
United States
Telephone:
+1 (310) 8537513
Website:
https://nanthealth.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
NH
ISIN:
US6301041074
Market cap:
$95.40 million
Shares in issue:
110.62 million
Sector:
Health Care Technology
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
NASDAQ Comb. Composite

Key personnel

  • Patrick Soon-Shiong
    Chairman of the Board, Chief Executive Officer, Founder
  • Bob Petrou
    Interim Chief Financial Officer
  • Ronald Louks
    Chief Operating Officer, Director

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.